20 Participants Needed

Cryoanalgesia for Phantom Limb Pain

FR
AT
Overseen ByAlparslan Turan, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Cryoanalgesia for Phantom Limb Pain?

Research shows that cryoanalgesia, which uses cold temperatures to target nerves, can significantly reduce phantom limb pain. In one study, 3 out of 5 patients experienced a 90% or greater reduction in pain, and another study reported profound pain relief after limb amputation with no long-term pain.12345

Is cryoanalgesia safe for treating phantom limb pain?

Cryoanalgesia, also known as cryoneurolysis, is generally considered safe with minimal risk of complications when performed using imaging guidance. Studies have shown no adverse events associated with the procedure in treating phantom limb pain.12346

How is the treatment Cryoanalgesia unique for phantom limb pain?

Cryoanalgesia is unique because it uses low temperatures to temporarily disable nerves, providing long-term pain relief without the need for ongoing medication. This method targets the peripheral nerves directly, which can lead to significant and lasting reduction in phantom limb pain, unlike traditional treatments that may not address the nerve-specific origin of the pain.12378

What is the purpose of this trial?

Investigators will evaluate preamputation cryoanalgesia on pain, mobility, opioid use and general physical and emotional disability using a pilot randomized trial design, to explore the amount and variability of improvement on those outcomes and to investigate the potentiality of conducting a future larger randomized controlled trial, which the investigators will assess quantitatively the benefits of cryoanalgesia.

Research Team

AT

Alparslan Turan, MD

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

This trial is for adults over 18 who are scheduled to have an amputation below the hip and including at least one bone in the foot. It's not suitable for those who don't meet these specific conditions.

Inclusion Criteria

I am scheduled for a leg amputation below the hip that includes part of my foot.

Exclusion Criteria

Pregnancy
Incarceration
My BMI is over 40.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preoperative Cryoanalgesia

Participants receive preoperative cryoanalgesia to improve post-amputation outcomes

1 week
1 visit (in-person)

Postoperative Monitoring

Participants are monitored for phantom limb pain, mobility, and opioid consumption

3 months
Weekly assessments (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Cryoanalgesia
  • Sham Cryoanalgesia
Trial Overview The study tests if pre-amputation cryoanalgesia (a freezing technique to reduce pain) can lessen phantom limb pain after surgery, compared to a sham procedure. The impact on pain, mobility, opioid use, and overall well-being will be measured.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: CryoanalgesiaExperimental Treatment1 Intervention
Participants will receive cryoanalgesia with the The iovera° system.
Group II: Sham CryoanalgesiaPlacebo Group1 Intervention
Participants will receive Sham cryoanalgesia with the The iovera° system.

Cryoanalgesia is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Cryoanalgesia for:
  • Chronic pain management
  • Phantom limb pain
  • Intercostal neuralgia
  • Lumbar facet pain
  • Trigeminal neuralgia
🇪🇺
Approved in European Union as Cryoanalgesia for:
  • Chronic pain management
  • Phantom limb pain
  • Intercostal neuralgia
  • Lumbar facet pain
  • Trigeminal neuralgia

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

Pacira Pharmaceuticals, Inc

Industry Sponsor

Trials
142
Recruited
14,300+
Headquarters
Tampa, USA
Known For
Non-opioid Pain Management
Top Products
Exparel, Zilretta, iovera
Dr. Jonathan Slonin profile image

Dr. Jonathan Slonin

Pacira Pharmaceuticals, Inc

Chief Medical Officer since 2020

BSc in Biomedical Engineering and MD from University of Miami, MBA from George Washington University

Frank D. Lee

Pacira Pharmaceuticals, Inc

Chief Executive Officer since 2024

BSc in Chemical Engineering from Vanderbilt University, MBA from Wharton Graduate School of Business

Findings from Research

A study involving 144 patients with lower-limb amputations found that cryoneurolysis did not significantly reduce phantom pain intensity compared to a sham treatment after 4 months, indicating limited efficacy for this intervention.
One serious adverse event occurred due to a protocol deviation, highlighting potential safety concerns associated with the procedure, particularly if not performed correctly.
Ultrasound-guided Percutaneous Cryoneurolysis to Treat Chronic Postamputation Phantom Limb Pain: A Multicenter Randomized Controlled Trial.Ilfeld, BM., Smith, CR., Turan, A., et al.[2023]
In a study of 5 patients with phantom limb pain (PLP), targeted treatment at the peripheral nerve location significantly reduced pain, with 3 patients experiencing over 90% relief after cryoanalgesia.
The findings suggest that identifying and treating peripheral pain sources can lead to long-term relief from PLP, highlighting the importance of addressing both central and peripheral factors in pain management.
Treatment of phantom limb pain by cryoneurolysis of the amputated nerve.Moesker, AA., Karl, HW., Trescot, AM.[2014]
In three cases of limb amputation, ultrasound-guided percutaneous cryoneurolysis provided effective pain relief in the immediate postoperative period without leading to persistent postsurgical or phantom limb pain.
The procedure was safe, with no reported adverse events, suggesting that cryoneurolysis could be a promising alternative to traditional local anesthetic techniques for managing post-amputation pain.
Ultrasound-Guided Percutaneous Cryoneurolysis for Postoperative Analgesia After Limb Amputation: A Case Series.Gabriel, RA., Finneran, JJ., Trescot, AM., et al.[2021]

References

Ultrasound-guided Percutaneous Cryoneurolysis to Treat Chronic Postamputation Phantom Limb Pain: A Multicenter Randomized Controlled Trial. [2023]
Treatment of phantom limb pain by cryoneurolysis of the amputated nerve. [2014]
Ultrasound-Guided Percutaneous Cryoneurolysis for Postoperative Analgesia After Limb Amputation: A Case Series. [2021]
Percutaneous Image-Guided Cryoablation for the Treatment of Phantom Limb Pain in Amputees: A Pilot Study. [2022]
Treating phantom limb pain: cryoablation of the posterior tibial nerve. [2022]
Percutaneous cryoanalgesia for pain palliation: Current status and future trends. [2021]
Percutaneous cryoanalgesia in pain management: a case-series. [2019]
Percutaneous cryoanalgesia in pain management: a case-series. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security